Market closed
Prices delayed by at least 15 minutes | Prices updated on 30 Apr 2025, 17.53 BST | Print
Genedrive PLC (GDR)
ORD 1.5POpen
1.505p
Previous close
1.505p
Trade high
1.54p
Volume
3,711,915
Year high
5.50p
Year low
1.208p
Dividend yield
–
Market capitalisation
£8.31 mn
P/E ratio
–
ISIN
GB00B1VKB244
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Share price
Company profile
Genedrive PLC is a holding company engaged in the molecular diagnostics business. It operates in one operating segment named Diagnostics which is engaged in the Genedrive Point of need molecular diagnostics platform for the diagnosis of infectious diseases and use in patient stratification (genotyping), pathogen detection, and other indications. Geographically the majority of the revenue is derived from the United Kingdom and also has its presence in Europe, United States ofAmerica and Rest of the World.
Recent trades
| Date | Time | Price | Quantity | Value (£) |
|---|---|---|---|---|
| 30/04/2025 | 05:07:50 | 1.53 | 113,705 | 1,739.69 |
| 30/04/2025 | 04:11:15 | 1.525 | 150,000 | 2,287.50 |
| 30/04/2025 | 04:02:22 | 1.5398 | 912 | 14.04 |
| 30/04/2025 | 04:01:47 | 1.525 | 30,000 | 457.50 |
| 30/04/2025 | 03:37:41 | 1.53 | 293,049 | 4,483.65 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.